The SpaceX IPO is garnering huge attention worldwide.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Uniquement les titres à fort signal — événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
The SpaceX IPO is garnering huge attention worldwide.
The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.77%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.73%. June E-mini S&P futures (ESM26 ) rose +0.78%, and June E-mini Nasdaq futures...
The nuclear energy start-up is losing a lot of money, burning cash, and issuing shares.
Oklo Inc. (NYSE:OKLO) is one of the unstoppable AI stocks to buy now. On May 12, Oklo announced a Strategic Partnership Project with Idaho National Laboratory/INL to use the Prometheus AI platform for accelerating advanced reactor and fuel-system designs. This collaboration aims to streamline engineering workflows and technical documentation for the Pluto reactor, an advanced […]
The S&P 500 Index ($SPX ) (SPY ) today is up +0.44%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. June E-mini S&P futures (ESM26 ) are up +0.40%, and June E-mini Nasdaq futures...
One catalyst could send Oklo shares soaring before July 4.
Oklo (OKLO) is back in focus after filing a new US$1b at-the-market common stock offering, shortly after reporting a first quarter 2026 net loss of US$33.07m and expanding its nuclear project pipeline. See our latest analysis for Oklo. Oklo’s share price has been volatile, with the stock down 5.39% over the last day and 12.51% over the week, yet still showing a 29.14% 1 month share price return and a very large 3 year total shareholder return as investors weigh fresh losses against regulatory...
Oklo just reported a wider-than-expected loss. Is it time to panic?
Siemens Energy, a nuclear play, nearly doubled earnings per share and raised outlook. Siemens stock jumped in a buy zone.
In October 2025, a company with zero revenue, no operating reactors, and a product still years away from commercialization briefly crossed a $30 billion valuation. That company was Oklo Inc. (NYSE: OKLO.
The AI-fueled nuclear rally may have put Oklo in the spotlight, but widening losses and mounting costs are starting to test Wall Street’s patience.
Nuclear reactor startup Oklo updated investors across its three businesses. A July 4 criticality target looms for Oklo and other nuclear stocks.
Jacob Dewitte: Thank you, Sam, and thank you, everyone, for joining us today. It has been almost exactly 2 years since Oklo became a public company. For Oklo, the story has increasingly moved from strategy to execution.
Oklo stock sank on Wednesday after the company said its quarterly loss widened year over year.
Oklo (NYSE:OKLO) reported a wider first-quarter 2026 loss as the advanced nuclear developer said it is moving further into asset deployment across its power, fuel and isotope businesses. Co-founder and Chief Executive Officer Jacob DeWitte told investors that the company has shifted “from strategy
Oklo’s losses deepened in its latest quarter, but the nuclear start-up remains committed to building a first-of-its-kind powerhouse that just cleared a major regulatory hurdle. Oklo finished the quarter with $1.59 billion in cash and cash equivalents and $614.5 million in marketable debt securities. With no revenue to analyze, Oklo’s health is difficult to gauge.
Oklo’s losses deepened in its latest quarter, but the nuclear start-up remains committed to building a first-of-its-kind powerhouse that just cleared a major regulatory hurdle. Oklo finished the quarter with $1.59 billion in cash and cash equivalents and $614.5 million in marketable debt securities. With no revenue to analyze, Oklo’s health is difficult to gauge.
Oklo Inc (OKLO) reports a net loss while strengthening its balance sheet and advancing key projects in the nuclear sector.
Major U.S. indices closed Tuesday on a mixed note, with the Dow Jones Industrial Average gaining 0.11% to 49,760.55. Meanwhile, the S&P 500 slipped 0.16% to 7,400.96 and the Nasdaq dropped 0.71% to 26,088.20. These are the top stocks that gained the attention of retail traders and investors through the day: Oklo Inc. (NYSE:OKLO) Oklo shares fell 5.76% to close at $73.63, with an intraday high of $76.68 and a low of $70.30. In the after-hours trading, the stock fell 2.89% to $71.50. Oklo reported
Oklo’s losses deepened in its latest quarter, but the nuclear start-up remains committed to building a first-of-its-kind powerhouse that just cleared a major regulatory hurdle. Oklo finished the quarter with $1.59 billion in cash and cash equivalents and $614.5 million in marketable debt securities. With no revenue to analyze, Oklo’s health is difficult to gauge.
Investing.com -- Oklo on Tuesday reported first quarter loss for FY 2026 that was in line with analysts’ estimates as it struggles to translate recent regulatory momentum into commercial progress.
Oklo prepares to report earnings for the first quarter late Tuesday. Intraday, Oklo stock tumbled near a key level with nuclear stocks broadly lower. Actual Oklo earnings will take a backseat when the company reports.
Oklo's latest quarterly results are due after the closing bell Tuesday, with traders expecting a big swing in the nuclear startup's stock following the report.
Oklo and Nano Nuclear Energy are designing microreactors for an era of AI data centers. Which one is the better deal today?
Pre-Market Stock Futures: Futures are trading mixed as we get set to start the new trading week, as reports indicate that President Trump declined Iran’s counteroffer for peace. This comes after a remarkable Friday, when stocks roared to record highs, driven primarily by a stronger-than-expected April jobs report that eased economic concerns and by a ... Here Are Monday’s Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bow